Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print RSS Feed

Search Results for 'tablets'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Norwich Pharma Services
By Stephanie Ferrell, Sr. Manager, Marketing Communications
body {font-family:arial;font-size:12px;} .heading {color:#4f5f6f;font:30px arial;} .subhead {font-weight:bold;} .title {color:#000000;font:22px arial;} .textl {padding-right:5px;width:390px;vertical-align:top;} .textr {padding-left:5px;width:390px;v… Read More »
Published September 26, 2014
NP-RD20, an R&D style tablet press, and the NP-155 rotary tablet press Read More »
Korsch Rotary Tablet Press, Model PH-106/DMS
Published September 10, 2014
One (1) used Korsch Rotary Tablet Press, Model PH-106/DMS. Rated up to 32,400 tablets/hour, 6-station, 40 KN compression pressure, keyed upper punch guides, 15 mm max tablet diameter, 15 mm max depth of fill; includes force feeder with feed hopper… Read More »
Formulating High Potency Drugs
By Robert Harris, Molecular Profiles
Published October 9, 2012
Product development challenges Read More »
By Gil Roth
Published June 22, 2011
Cancels NDA and MAA and withdraws MS treatment from approved markets Read More »
Metal Contamination in Bio- pharmaceutical Drugs
By Mary Stellmack and Dr. Kent Rhodes
Published October 8, 2010
Solving a puzzle without all the pieces Read More »
Published July 28, 2010
EMD Serono’s NDA for Cladribine Tablets has accepted for filing as a therapy for relapsing forms of multiple sclerosis (MS). Read More »
Published January 2, 2007
Ranbaxy Laboratories has received approval from the FDA to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg. The Office of Generic Drugs, U.S. FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same the… Read More »
Published September 24, 2014
ADHD drugs will employ Catalent’s OSDrC OptiDose drug delivery platform Read More »
By Kevin Lesnewski, Manager, Marketing & Business Intelligence
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On